Fmr LLC Buys 9,137 Shares of Aemetis, Inc. (NASDAQ:AMTX)

Fmr LLC raised its position in Aemetis, Inc. (NASDAQ:AMTX) by 68.2% during the third quarter, according to its most recent filing with the SEC. The firm owned 22,531 shares of the specialty chemicals company’s stock after purchasing an additional 9,137 shares during the period. Fmr LLC’s holdings in Aemetis were worth $52,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Hutchinson Capital Management CA acquired a new position in Aemetis in the second quarter valued at $70,000. Rhumbline Advisers raised its position in shares of Aemetis by 2,837.1% in the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after acquiring an additional 50,528 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in shares of Aemetis in the 2nd quarter valued at about $306,000. Finally, Susquehanna Fundamental Investments LLC boosted its position in shares of Aemetis by 287.4% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock valued at $379,000 after purchasing an additional 93,536 shares in the last quarter. 27.02% of the stock is owned by institutional investors.

Aemetis Stock Performance

AMTX stock opened at $2.63 on Wednesday. The stock’s 50 day simple moving average is $3.30 and its 200 day simple moving average is $2.99. The company has a market cap of $130.80 million, a P/E ratio of -1.16 and a beta of 1.35. Aemetis, Inc. has a fifty-two week low of $2.10 and a fifty-two week high of $7.03.

Aemetis (NASDAQ:AMTX) last issued its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The firm had revenue of $81.44 million for the quarter, compared to analyst estimates of $77.79 million. During the same period in the previous year, the company earned ($0.59) earnings per share. Equities analysts predict that Aemetis, Inc. will post -2.02 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages have weighed in on AMTX. HC Wainwright reiterated a “buy” rating and issued a $28.00 target price on shares of Aemetis in a report on Monday. Ascendiant Capital Markets lowered their price objective on shares of Aemetis from $20.00 to $19.00 and set a “buy” rating for the company in a research note on Tuesday, September 3rd. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, Aemetis currently has a consensus rating of “Moderate Buy” and an average target price of $12.95.

Aemetis Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.